Correspondence 0001683168-26-000306 from AETHLON MEDICAL INC (AEMD)
AETHLON MEDICAL INC
Date: Jan. 14, 2026 · CIK: 0000882291 · Accession: 0001683168-26-000306
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292598
Letter
Aethlon Medical, Inc.
11555 Sorrento Valley Road, Suite 203
San Diego, CA 92121
January 14, 2026
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Aethlon Medical, Inc.
Registration Statement on Form S-1 Filed January 7, 2026
File No. 333-292598
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), Aethlon Medical, Inc., a Nevada corporation (the "Registrant"), hereby respectfully requests that the United States Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Registration Statement on Form S-1 (File No. 333-292598) to become effective on Friday, January 16, 2026, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant understands that the Commission will consider this request as a confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes its counsel, Dennis J. Doucette, Esq. of Procopio, Cory, Hargreaves & Savitch LLP, to orally modify or withdraw this request for acceleration. Please contact Mr. Doucette at (858) 720-6322 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted.
Sincerely,
AETHLON MEDICAL, INC.
Show Raw Text
CORRESP 1 filename1.htm Aethlon Medical, Inc. 11555 Sorrento Valley Road, Suite 203 San Diego, CA 92121 January 14, 2026 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Aethlon Medical, Inc. Registration Statement on Form S-1 Filed January 7, 2026 File No. 333-292598 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), Aethlon Medical, Inc., a Nevada corporation (the "Registrant"), hereby respectfully requests that the United States Securities and Exchange Commission (the "Commission") take appropriate action to cause the above-referenced Registration Statement on Form S-1 (File No. 333-292598) to become effective on Friday, January 16, 2026, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant understands that the Commission will consider this request as a confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement. The Registrant hereby authorizes its counsel, Dennis J. Doucette, Esq. of Procopio, Cory, Hargreaves & Savitch LLP, to orally modify or withdraw this request for acceleration. Please contact Mr. Doucette at (858) 720-6322 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted. Sincerely, AETHLON MEDICAL, INC. /s/ James B. Frakes James B. Frakes Chief Executive Officer and Chief Financial Officer